Enhertu is already approved as a second-line or later therapy for HER2-positive breast cancer based on the results of the ...

The data show that a regimen based on Trodelvy and PD-1 inhibitor Keytruda (pembrolizumab) was better than Keytruda plus ...

Sanofi and Regeneron's Dupixent (dupilumab) has been approved by the FDA for the treatment of chronic spontaneous urticaria ...

March was a light month across the board for hires news, but the digital and supplier sectors in biopharma saw a spat of ...

Join the TPD & Induced Proximity Pharma Partnering Summit to accelerate partnership interest in your protein degradation ...

While it sends some signals about the priorities of new FDA Commissioner Dr Martin Makary, the actual impact of the directive ...

GSK's Blenrep (belantamab mafodotin) has officially been approved by the UK's Medicines and Healthcare products Regulatory Agency (MHRA), its first approval in the world for the multiple myeloma drug ...

A complaint against GSK accusing it of a major breach of the pharma industry's code of practice on prescribing information ...

Merida Biosciences has emerged from Third Rock Ventures with $121 million in first-round financing for a pipeline of drugs ...

The EU approval comes after Eisai and Biogen were given approval for a new once-monthly intravenous maintenance dose of ...

An international agreement on pandemic preparedness is finally complete after three years of negotiation. The World Health ...

Click Therapeutics' digital therapeutic (DTx) CT-132 has been approved by the FDA, becoming the first treatment of its type ...